Verrica Pharmaceuticals Inc. (VRCA) AI Dilution Summary

Cash was $11,198,000 at 2026-06-30, against estimated monthly burn of $3,092,667. The company's at-the-market program is marked active and is subject to the Form S-3 I.B.6 baby-shelf limitation. Dilution here is driven primarily by S-3 shelf 333-285719.